These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16101562)

  • 1. Endothelin receptor antagonists: another potential alternative for cardiovascular diseases.
    Tostes RC; Muscará MN
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):287-301. PubMed ID: 16101562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin and endothelin antagonists: pharmacology and clinical implications.
    Lüscher TF; Wenzel RR
    Agents Actions Suppl; 1995; 45():237-53. PubMed ID: 7717186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor antagonists and their developing role in cardiovascular therapeutics.
    Dupuis J
    Can J Cardiol; 2000 Jul; 16(7):903-10. PubMed ID: 10934309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic implications of endothelin antagonists for cardiovascular diseases].
    Abassi Z; Ramadan R; Schwartz H; Hoffman A
    Harefuah; 2004 Jan; 143(1):47-53, 84. PubMed ID: 14748289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
    Rafnsson A; Shemyakin A; Pernow J
    Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin and endothelin antagonists in hypertension.
    Schiffrin EL
    J Hypertens; 1998 Dec; 16(12 Pt 2):1891-5. PubMed ID: 9886874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelin receptor antagonists--a brief description of the new class of drugs].
    Kowalczyk A; Kołodziejczyk M; Gorąca A
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():1076-80. PubMed ID: 25228516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin receptor antagonists and cardiovascular diseases of aging.
    Love MP; McMurray JJ
    Drugs Aging; 2001; 18(6):425-40. PubMed ID: 11419917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible therapeutic role of endothelin antagonists in cardiovascular disease.
    Ram CV
    Am J Ther; 2003; 10(6):396-400. PubMed ID: 14624276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
    Warner TD; Allcock GH; Corder R; Vane JR
    Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endothelin system as target for therapeutic interventions in cardiovascular and renal disease.
    Eroglu E; Kocyigit I; Lindholm B
    Clin Chim Acta; 2020 Jul; 506():92-106. PubMed ID: 32151622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelins in cardiovascular biology and therapeutics.
    Dhaun N; Webb DJ
    Nat Rev Cardiol; 2019 Aug; 16(8):491-502. PubMed ID: 30867577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin ET
    Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
    J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin: new discoveries and rapid progress in the clinic.
    Webb DJ; Monge JC; Rabelink TJ; Yanagisawa M
    Trends Pharmacol Sci; 1998 Jan; 19(1):5-8. PubMed ID: 9509892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
    Hay DW; Luttmann MA; Beck G; Ohlstein EH
    Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Role of Endothelin in Early Vascular Aging.
    Trindade M; Oigman W; Fritsch Neves M
    Curr Hypertens Rev; 2017; 13(1):33-40. PubMed ID: 28413991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms.
    Suga S; Yasui N; Yoshihara F; Horio T; Kawano Y; Kangawa K; Johnson RJ
    J Am Soc Nephrol; 2003 Feb; 14(2):397-406. PubMed ID: 12538740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.